Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGunsynd Regulatory News (GUN)

Share Price Information for Gunsynd (GUN)

Share Price is delayed by 15 minutes
Get Live Data
0.10    -0.003 (-2.91%)
Bid:
0.09
Ask:
0.11
Spread: 0.02 (22.222%)
Market Cap: £1.48m
GUN Live PriceLast checked at - London Stock Exchange

Intraday Gunsynd Share Chart

Director/PDMR Shareholding

16 Apr 2026 07:00

RNS Number : 6560A
Gunsynd PLC
16 April 2026
 

Gunsynd PLC("Gunsynd" or the "Company")

Director/PDMR Shareholding

Gunsynd PLC (AIM: GUN) announces that it received notification on 15 April 2026 that Hamish Harris, Chairman of the Company, made the following purchases of ordinary shares in the capital of the Company on 15 April 2026.

Director

Purchase price (Aggregated)

Ordinary shares purchased

Resultant interest in ordinary shares

Resultant percentage of issued ordinary shares

Hamish Harris

0.108p

4,000,000

28,494,809

1.76 %

 

Further details are set out in the Notification of Dealing Form below.

This announcement contains inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.

For further information, please contact:

Gunsynd plc

Hamish Harris

+44 (0)20 3582 6636

Cairn Financial Advisers LLP

Liam Murray / James Western

+44 (0)20 7213 0880

 

AlbR Capital Limited

Lucy Williams

 

 

 

 

 

+44 (0)20 7469 0936

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

Details of the persons discharging managerial responsibilities / person closely associated

 

a)

Name

 

Hamish Harris

2

Reason for the notification

 

a)

Position/Status

 

Chairman

b)

Initial notification/ Amendment

 

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Gunsynd plc

b)

LEI

 

21380068N2D57QUG1L78

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Identification code

 

 

 Ordinary shares of 0.085 pence each

 

 

GB00BMD6PM55

b)

Nature of the transaction

Purchase of ordinary shares

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

0.108p

4,000,000

 

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

 

 

 

See above

 

e)

Date of transaction

 

15 April 2026

f)

Place of transaction

 

London Stock Exchange

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHZZGMDRKFGVZM
Date   Source Headline
30th Sep 20117:00 amRNSBusiness Update
27th Sep 20117:00 amRNSPosting of Circular and Notice of General Meeting
8th Jul 20117:00 amRNSChange of Registered Office
21st Jun 201111:00 amRNSDirectorate Change
23rd May 201111:45 amRNSResult of General Meeting
11th May 201111:17 amRNSDirector's Dealing
6th May 20117:00 amRNSAcquisition and Placing to raise £2 million
27th Apr 20112:30 pmRNSBusiness Update
8th Mar 20117:00 amRNSInterim Results
2nd Mar 20113:12 pmRNSHolding(s) in Company
25th Feb 20117:00 amRNSHolding(s) in Company
20th Jan 20111:23 pmRNSResult of AGM
17th Jan 20117:00 amRNSSyntopix to research biofilms for Beiersdorf AG
14th Jan 201110:13 amRNSPosting of Annual Report and notice of AGM
3rd Dec 20107:00 amRNSGrant of share options to Directors
29th Nov 20107:00 amRNSFinal Results
11th Nov 20107:00 amRNSAppointment of Broker
1st Nov 20107:00 amRNSSecond Agreement with Sinclair Pharma
29th Sep 20105:05 pmRNSHolding(s) in Company
27th Sep 20102:51 pmRNSHolding(s) in Company
23rd Aug 20107:00 amRNSAgreement with Global Consumer Products Company
22nd Jun 20103:20 pmRNSDirectorate Change
22nd Apr 20107:00 amRNSAgreement with Sinclair Pharma plc
31st Mar 201011:25 amRNSResult of General Meeting
15th Mar 201011:08 amRNSProposed Fundraising
12th Mar 20107:00 amRNSInterim Results
3rd Feb 20107:00 amRNSDirectorate Change
2nd Feb 20102:30 pmRNSResult of AGM
7th Jan 20107:00 amRNSPreliminary results
12th Nov 20097:00 amRNSBusiness Update
12th Nov 20097:00 amRNSClinical results from Phase II cosmetic study
28th Apr 20097:00 amRNSHalf Yearly Report
14th Apr 20097:00 amRNSRe Contract
3rd Nov 20087:00 amRNSFinal Results
25th Sep 20087:00 amRNSChange of Adviser
29th Aug 20087:00 amRNSTotal Voting Rights
12th Aug 200811:58 amRNSHolding(s) in Company
6th Aug 20081:13 pmRNSResult of EGM & Director's In
15th Jul 20087:00 amRNSProposed fundraising
3rd Jul 20087:00 amRNSProctor & Gamble Agreement
24th Apr 20087:00 amRNSInterim Results
25th Feb 20087:00 amRNSPositive Trial Results
4th Feb 200810:51 amRNSHolding(s) in Company
21st Dec 20072:50 pmRNSOral Healthcare Agreement
15th Nov 20074:03 pmRNSAnnual Report and Accounts
18th Oct 20077:01 amRNSPreliminary Results
16th Aug 20077:00 amRNSPhase I Results
13th Jun 20077:01 amRNSPhase I Acne Trial Starts
8th May 20077:02 amRNSCRO Appointment
30th Apr 20079:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.